Survey on the impact of urban nature on stress and health
Anonymous Survey Among Local Residents on the Impact of the Planned Measures in the Five Partner Cities of the DivAirCity Project on Their Social Life, Health and Well-being
This study looks at whether adding green spaces and clean air features in cities can help reduce stress and improve the health of people living there.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin) |
| Trial ID | NCT06274229 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effects of stress-reducing and air quality-improving installations in urban areas on the psychological well-being of residents. By comparing physiological and psychological stress levels before and after the implementation of these interventions in five cities, the study will evaluate changes in health factors at intervention sites versus control sites. The research is part of the European Council Horizon 2020 program, focusing on enhancing urban environments to promote better health outcomes for city dwellers.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who live or work near the intervention or control sites in urban areas.
Not a fit: Patients who do not reside or work in the vicinity of the study sites may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved mental health and well-being for urban residents by demonstrating the benefits of green spaces and reduced pollution.
How similar studies have performed: Previous studies have shown positive health impacts from urban green spaces, suggesting that this approach has potential based on existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must live or work at or near the installation (intervention group) or control site (control group) Exclusion Criteria: * none
Where this trial is running
Berlin
- Charité -- Universitaetsmedizin Berlin — Berlin, Germany (Recruiting)
Study contacts
- Principal investigator: Andreas Michalsen, Prof MD — Charite Universitaetsmedizin Berlin
- Study coordinator: Farid I Kandil, PhD
- Email: farid-ihab.kandil@charite.de
- Phone: +493080505
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.